For example, EVs that have been modified with the GE11 peptide can target the EGFR, a highly expressed target in tumor cells, by binding specifically to other membrane proteins on their surface, such as PDGFR, acting as anchor points for targeting motifs.578 Following the encapsulation of paclitaxel, EVs containing aminoethylanisamide-polyethylene glycol exhibited enhanced anticancer effects, specifically targeting LC.579 EVs have intrinsic targeting properties for drug delivery, as their lipid composition and protein content can influence their tropism to specific organs. Here, EGFR is linked to neoplasm.